Round tables
Web-table’s aim is to discuss some important and debated points in gastric cancer treatment with all participants, inviting researchers who published high-quality articles in the literature.
In a preliminary phase, the authors of important studies will be asked to present a contribution emerged from their published works after new experience and knowledge. The answers will be presented , in form of short articles, on the conference web site and these will represent a significative bibliographic reference. All users will be able to read these articles at any time. Available Authors’ answers are set with a bullet (•).
The actual Round Tables will be open at different times, for the duration of one month to allow a concentrated and qualified discussion.
Each Round Table will start with a set of questions proposed by the respective chairmen. For each question every participant will be able to post and comments after a free web registration. This is not a chat; all contributes will be preliminary submitted to the chairman and then published.
At the end of the discussion, chairmen will draw conclusions that will be published on the web site, at the Congress, and on international journals.
Separate certificate for Web Round Tables will be available at the Congress.
| Round table | Chairman | Co-Chairman | Bibliography | Discussion | Month (2012) | |
|---|---|---|---|---|---|---|
| How to predict recurrence and prognosis Conclusions available | Alberto Di Leo | D.Marrelli (I), M. Monti (I), S.H.Noh (KR) |  |
 |
March |  |
| Resection Margins and prognosis Conclusions available |
Giuliano La Barba | P.Bandhari (UK), S.Cascinu (I), H.K. Yang (KR) | |
|
March | |
| Extended criteria for ESD Conclusions available |
Luca Saragoni | F.Catalano (I), T.Gotoda (JP), B.Rembaken (UK), E.Ricci (I), A.Trecca(I) | |
|
March | |
| Gastric Gist. Is resection always indicated? | Filippo Catalano | M. Catarci (I), L.Saragoni (I), A.Trecca (I) | |
 |
April |  |
| Follow up for diagnosis of recurrence and late complications: clinical utility? | Luca Baiocchi | Y.Kodera (JP), D.Marrelli (I), F.Pacelli (I) | |
|
April | |
| Hipec and gastric cancer | Luigina Graziosi | A.Garofalo (I), S.Kusamura (I) | |
|
April | |
| Why, when and how to palliate advanced forms? | Marco Catarci | F.Calabrò (I), A.Mirri (I), J.E.Van Hooft (NL) | |
|
April | |
| How to tailor surgical approach and lymphadenectomy | Alberto Marchet | H.Hartgrink (NL), S.Mocellin (I), T.Sano (JP) | |
|
April | |
| Micrometastasis and prognosis | Luca Saragoni | F.Carneiro (PT), G.Y.Lauwers (USA), T.Shimoda (JP), C.Vindigni (I) | |
|
April | |
| How to tailor preoperative work-up | Stefano Rausei | J.A.Ajani (USA), S.Cascinu (I), K.Ott (D) | |
|
April | |
| How to standardize peritoneal cytology | Anna Tomezzoli | F.R.Piro (I) | |
|
May | |
| TNM Staging after neoadjuvant CHT | Anna Tomezzoli | K.Ott (D), C.Pedrazzani (I), G.Verlato (I), A.Zanoni (I) | |
|
May | |
| Biomarkers and molecular biology in gastric cancer | Gianni Corso | R.Almeida (PT), F.Carneiro (PT), L.David (PT), C.Figueiredo (PT), J.C.Machado (PT), C.Oliveira (PT), H.Osorio (PT), C.Reis (PT), R.Seruca (PT) | |
|
May | |
| Different Neoadiuvant treatments for eastern and western patients? | Gianni Mura | C.Milandri (I), M.Scartozzi (I) | |
|
May | |
| Radiotherapy in gastric and cardia cancer | Massimo Giannini | A.De Paoli (I), D.Genovesi (I) S.Manfridda (I), V.Valentini (I) | |
|
May | |
| Laparoscopy and robotic treatment. What is Evidence based? | Simone Giacopuzzi | S.Caruso (I), A.Coratti (I), S.Preston (UK), A.Sansonetti (I), I.Uyama (JP) | |
|
May | |
| National guidelines and evidence based medicine | Marco Bernini | C.Shuhmacher (D), C.Pedrazzani (I), C.Linari (I) | |
|
May | |
| PET: preoperative staging or prognostic factor? | Andrea Moretti | F.Mohsen (I), A.Musto (I) | |
|
May | |
| How to manage aged patients or those with severe comorbidities | Roberto Persiani | A.Biondi (I) | |
|
May | |
| Problems in surgical trials | Giuseppe Verlato | O.Nanni (I), M.G.Valsecchi (I) | |
|
June | |
ROUND TABLES RULES
1. The Web Round Table constitute an open scientific debate for the participants of the 10th International Gastric Cancer Congress. The Web Round Tables have a specific interest in gastric cancer.
2. Registration for the forum has the value of pre-registration to the Conference.
3. All content for debate is moderated by a chairman. This is not a chat.
4. Topics not related to the round table will not be published.
5. Specific Request for personal clinical issues will not be published.
6. The roundtables are addressed to the scientific community and not to patients, who have to ask to their family doctors.
7. Improper or offensive statements will not be published.
8. Debates involving only few people will not be continued.
9. Nobody will be forced to answer personal questions.
10. Chairmen will be supported by co-chairmen for a better moderation
